SynthesisBMC endocrine disorders2026
Effect of diabetes self-management education in type 2 diabetes management - a systematic umbrella review of meta-analysis.
Synthesis in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundType 2 diabetes is a chronic metabolic health condition that affects millions of people worldwide. Diabetes self-management education (DSME) is an effective intervention approach and the potential to enhance the health status of diabetic patients and mitigate complications to the greatest possible extent. However, no systematic synthesis or comprehensive report has been conducted to date on the impact of DSME in patients with diabetes. This review aimed to identify existing evidence on DSME care for diabetes management and the extent to which interventions are included in the evidence base.
methodsPubMed, EMBASE, Web of Science, and Cochrane library databases were searched from inception to the December 31, 2025. Systematic reviews with meta-analyses of randomized controlled trials were included, reporting an effect size to calculate the association between DSME and the outcomes related to HbA1c. Quality of each review was appraised using a Measurement Tool to Assess Systematic Reviews (AMSTAR).
resultsA total of 12 meta-analyses were included. In this study, we suggested that DSME will leads to a decrease in HbA1c (effect size [ES] = − 0.34%, 95% confidence interval [CI]: − 0.43% to − 0.25%). The associations of self-management intervention (ES = − 0.35%, 95%CI: − 0.50% to − 0.20%) and technology-based intervention (ES = − 0.33%, 95%CI: − 0.46% to − 0.20%) with lower HbA1c levels were observrd. Overall quality of the included reviews was high or moderate.
conclusionsThis umbrella review consolidates the existing evidence demonstrating that DSME has a significant positive impact on HbA1c levels, among individuals with type 2 diabetes. Future research should prioritize the development and implementation of integrated DSME models to enhance their effectiveness across various health outcomes and ensure adaptability to diverse population needs. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.